Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B

<div>Factors associated with the time taken to switch to NA therapy from ETV monotherapy. The baseline ALT (a), HBV DNA (b), and HBcrAg (c) levels were not significantly correlated with the time taken to switch to NA therapy.</div>

Canadian Journal of Gastroenterology and Hepatology

fig3

Figure 3

Figure 3: Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B 